7, Sangdo-ro, Dongjak-gu, Seoul, Korea 06955   Tel : 02)8288-114   Fax : 02)8288-029   CS : 02)8288-114

Copyright © 2015 Bukwang Pharmaceutical Co., Ltd.All Rights Reserved.

  • Facebook Basic Square
  • Google+ Basic Square

Business Overview

 

Locations

- Head office : 7, Sangdo-ro, Dongjak-gu, Seoul

- Factory 1 : 63, Wonsi-ro, Danwon-gu, Ansan-si, Gyeonggi-do

- Factory 2 : 47, Neungan-ro, Danwon-gu, Ansan-si, Gyeonggi-do

- R&D Center : 7, Sangdo-ro, Dongjak-gu, Seoul

 

Co-presidents

- CEO Dr. Hee-Won Yoo, CEO Mr. Sang-Hoon Kim

 

Date of establishment

- 17th October, 1960

 

Date of stock listing

- 5th August, 1988

 

Par value

- KRW 500

 

Gross capital

- KRW 15.5 bil.

Number of employees

- 615 (as of 31st March, 2015)

 

Account settlement

- December

 

Main creditor bank

- Shinhan Bank (Boramae station branch)

 

External auditor

- Samil PricewaterhouseCoopers Korea

 

Subsidiary companies

- Bukwang C&C Co., Ltd. (share ownership: 100%)

- Contera Pharma ApS (share ownership: 100%)

 

Related company

- Anterogen Co., Ltd. (share ownership: 24.70%)

|    ​Korean    |